NCT01945281
|
2014-01-01 |
Safety, Tolerability, and Efficacy of Caspofungin Versus Amphotericin B Deoxycholate in the Treatment of Invasive Candidiasis in Neonates and Infants (MK-0991-064)
|
Phase 2
|
Recruiting
|
NCT00815516
|
2012-06-01 |
Study to Compare the Efficacy and Safety of Micafungin Versus Conventional Amphotericin B for the Treatment of Neonatal Candidiasis
|
Phase 3
|
Terminated
|
NCT01310738
|
2011-02-01 |
Efficacy and Safety Study of Drugs for Treatment of Visceral Leishmaniasis in Brazil
|
Phase 4
|
Terminated
|
NCT00696969
|
2008-06-01 |
Safety and Efficacy Study to Evaluate Different Combination Treatment Regimens for Visceral Leishmaniasis
|
Phase 3
|
Completed
|
NCT00628719
|
2008-02-01 |
Single Infusion of Liposomal Amphotericin B in Indian Visceral Leishmaniasis
|
Phase 3
|
Completed
|
NCT01032187
|
2007-10-01 |
Amphotericin B to Treat Visceral Leishmaniasis in Brazilian Children
|
Phase 4
|
Completed
|
NCT00523965
|
2007-09-01 |
Combination Therapy in Indian Visceral Leishmaniasis
|
Phase 3
|
Completed
|
NCT00422188
|
2007-01-01 |
ATX-101 (Sodium Deoxycholate for Injection) for the Treatment of Superficial Lipomas
|
Phase 1
|
Completed
|
NCT00361517
|
2006-06-01 |
To Determine Whether Galactomannan Test Will Help to Detect Fungal Infections Early and Hence Start Treatment Early
|
Phase 3
|
Terminated
|
NCT00003031
|
1997-06-01 |
Comparison of Voriconazole and Amphotericin B in Treating Patients With Aspergillosis
|
Phase 3
|
Completed
|
NCT00002742
|
1996-01-01 |
Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic Cancer
|
Phase 3
|
Completed
|